pandemic news from FierceBioResearcher
News
Vaccine a success for human-to-human H5N1 case
Breakthrough in understanding mechanism of bird flu
Glaxo turns to auto company for research ideas
GlaxoSmithKline had to play a serious game of catch-up in its quest to develop a new vaccine for cervical cancer. Four years ago, Glaxo's vaccines division--GSK Bio--concluded that it was two years behind Merck's program for an HPV vaccine. In order to bridge that yawning gap, researchers at the company adopted a new approach developed by automaker Renault called the "one roof" approach. The company plucked a variety of experts it needed from different fields and put them together under …
Read more...Scientists find potential Achilles heel in flu virus
Scientists at Rice University and the University of Texas in Austin say that they've found a weakness in the flu virus--both common flu viruses as well as bird flu--that could be a very effective target for new antiviral drugs. The target is the nucleoprotein, the flexible tail loop of the flu protein, often referred to as NP in shorthand. Any changes in the tail prevent the NPs from stacking together, a process that's necessary before cells begin to create the virus. A new antiviral that …
Read more...Indonesia opens up access to bird flu gene codes
Just before Indonesia announced its forty-throed bird flu death, researchers around the globe got some welcome news. Indonesian health officials announced that they were taking off the restrictions on sharing the gene sequences of its avian flu virus. Those sequences, the genetic code to the virus, are considered crucial to understanding how the disease is changing. Indonesia has presented some of the most alarming cases of avian flu clusters, including family clusters where the disease …
Read more...Avian flu: Research finds virus won't mutate easily
Scientists at the CDC reported a project failure late last week that many researchers in the field were only too happy to see. They engineered genetic changes to see if they could make the deadly A-H5N1 virus more easily transmittable among people. It didn't work. That doesn't mean that the virus, which has claimed 134 lives, can't mutate into a virus that could trigger a human pandemic. But it does mean that a mutation probably won't happen easily.
Undertaking their work in a …
Read more...Get more pandemic coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

